Bruker Board OKs $225M Share Repurchase Program | GenomeWeb

NEW YORK (GenomeWeb) – Bruker announced today that its board of directors has approved a new $225 million share repurchase program.

The firm said the repurchase program commenced yesterday and will run for two years. During that time Bruker may repurchase its common stock from time to time in amounts and at prices that it deems appropriate. It added that the repurchases may be made on the open market, privately negotiated, or through other transactions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.